Covered recipient · General Payments record
KHARY EDWARDS
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2020–2024
$3,142.97
- Reported across 131 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,466.25 | 65 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $218.68 | 10 |
| Amgen Inc. | $171.23 | 9 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $134.59 | 7 |
| Abbott Laboratories | $113.92 | 5 |
| Novo Nordisk AS | $86.64 | 4 |
| Antares Pharma, Inc. | $79.29 | 3 |
| Mallinckrodt Hospital Products Inc. | $58.23 | 2 |
| Amphastar Pharmaceuticals, Inc. | $45.95 | 3 |
| Genentech USA, Inc. | $38.33 | 2 |
| Tandem Diabetes Care, Inc. | $35.41 | 1 |
| CeQur Corporation | $35.10 | 1 |
| Medtronic, Inc. | $32.58 | 1 |
| SOBI, INC | $30.16 | 1 |
| Actelion Pharmaceuticals US, Inc. | $29.43 | 1 |
| E.R. Squibb & Sons, L.L.C. | $28.59 | 1 |
| Ascendis Pharma Inc | $27.61 | 1 |
| Kyowa Kirin, Inc. | $26.80 | 1 |
| Radius Health, Inc. | $26.33 | 1 |
| SANOFI-AVENTIS U.S. LLC | $25.96 | 1 |
| Fresenius Kabi USA, LLC | $25.25 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.83 | 1 |
| Aurinia Pharma U.S., Inc. | $24.51 | 1 |
| Insulet Corporation | $23.98 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.06 | 1 |
| ANI Pharmaceuticals, Inc. | $22.99 | 1 |
| Acerta Pharma LLC | $20.93 | 1 |
| ABBVIE INC. | $19.84 | 1 |
| Amneal Pharmaceuticals LLC | $18.36 | 1 |
| Organon LLC | $17.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (65)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.